Discussion of Vaccination with a Family Physician or Pediatrician (n = 81).

<p>Discussion of Vaccination with a Family Physician or Pediatrician (n = 81).</p

Variables Associated with Naturopathic Patients having a Partially Vaccinated or Unvaccinated Child.

<p>OR = Odds Ratio.</p><p>95% CI = 95% Confidence Interval.</p

Characteristics of Survey Respondents (n = 95).

<p>Key: SD = standard deviation.</p><p>* = respondents could endorse more than 1 option.</p>‡<p> = respondents are limited to those parents that reported having felt pressure to vaccinate their children (n = 57).</p

Discussion of Vaccination with a Naturopathic Physician (n = 45).

<p>Discussion of Vaccination with a Naturopathic Physician (n = 45).</p

Study Features Associated with Annual Citation Rate

<p>95% CI = 95% confidence interval</p>†<p>n/a = not applicable (variable was not included in the model)</p>*<p>Since a significant interaction term between these two variables was included in the final multivariable model, their effects are dependent on each other and are presented together.</p

Characteristics of the index article cohort.

<p>Characteristics of the index article cohort.</p

Network meta-analysis results for serum parathyroid hormone.

<p>Forest plot of effectiveness outcome for mean parathyroid hormone reduction at the end of the study period; MD: Mean difference; Crl: Credible interval; PrI: predictive interval.</p

Direct, indirect, and NMA estimates of parathyroid hormone with 95% credible intervals and GRADE assessments from each pairwise comparison within the phosphate-binder network.

<p>Direct, indirect, and NMA estimates of parathyroid hormone with 95% credible intervals and GRADE assessments from each pairwise comparison within the phosphate-binder network.</p

PRISMA flow diagram.

<p>PRISMA flow diagram.</p

Network of clinical trials of phosphate binders in patients with chronic kidney disease: outcome mean change from baseline in serum calcium concentration.

<p>Netplot of effectiveness outcome for mean calcium reduction at the end of the study period. Network of randomized controlled trials comparing different phosphate binders for mean change in serum calcium. Lines connect different phosphate binder categories with direct evidence. The width of lines correlates the number of RCTs for each direct comparison while the size of the nodes correlates with the total sample size. Abbreviations: cal: calcium; calmag: calcium and magnesium; calsev: calcium and Sevelamer; Lant: lanthanum; seve: Sevelamer.</p